Comparison of the pathogenicity and virus shedding of SARS CoV-2 VOC 202012/01 and D614G variant in hamster model
Preprint
- 25 February 2021
- preprint
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
The emergence of SARS-CoV-2 variants has posed a serious challenge to public health system and vaccination programs across the globe. We have studied the pathogenicity and virus shedding pattern of the SARS-CoV-2 VOC 202012/01 and compared with D614G variant in Syrian hamsters. VOC 202012/01 could produce disease in hamsters characterized by body weight loss and respiratory tract tropism but mild lung pathology. Further, we also documented that neutralizing antibodies developed against VOC 202012/01 could equally neutralize D614G variant. Higher load of VOC 202012/01 in the nasal wash specimens was observed during the first week of infection outcompeting the D614G variant. The findings suggest increased fitness of VOC 202012/01 to the upper respiratory tract which could lead to higher transmission. Further investigations are needed to understand the transmissibility of new variants. One-Sentence Summary SARS-CoV-2 VOC 202012/01 infected hamsters demonstrated high viral RNA shedding through the nasal secretions and significant body weight loss with mild lung pathology compared to the D614G variant.Keywords
This publication has 22 references indexed in Scilit:
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 VirusCell, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020
- Pathogenesis and transmission of SARS-CoV-2 in golden hamstersNature, 2020
- Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infectionIndian Journal of Medical Research, 2020
- Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and TransmissibilityClinical Infectious Diseases, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- First isolation of SARS-CoV-2 from clinical samples in IndiaIndian Journal of Medical Research, 2020
- Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in IndiaIndian Journal of Medical Research, 2020
- Genomic Analysis of the Emergence, Evolution, and Spread of Human Respiratory RNA VirusesAnnual Review of Genomics and Human Genetics, 2016
- A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12American Journal of Epidemiology, 1938